文献速递肿瘤 PET/CT

68Ga-PSMA PET/CT显像在多发性骨髓瘤中的应用

68Ga-PSMA PET/CT Imaging in Multiple Myeloma.
PubMed 文献 · Clin Nucl Med · 2017-01-01

本文描述68Ga-PSMA PET/CT在多发性骨髓瘤显像中的应用,病灶对该示踪剂摄取强烈,其机制可能为肿瘤新生血管形成;

要点

  • 68Ga-PSMA PET/CT可用于多发性骨髓瘤病灶显像,病灶摄取强烈。
  • 非前列腺恶性肿瘤中68Ga-PSMA摄取增高可能归因于肿瘤新生血管形成。

核心结论

  • 68Ga-PSMA PET/CT可用于多发性骨髓瘤显像,病灶对68Ga-PSMA摄取强烈。
  • 非前列腺恶性肿瘤中68Ga-PSMA摄取增高的机制可能为肿瘤新生血管形成。

研究设计与样本

  • 本文为病例报告,描述68Ga-PSMA PET/CT在多发性骨髓瘤显像中的应用,未报告样本量与具体病例数。

主要发现

  • 多发性骨髓瘤病灶对68Ga-PSMA摄取强烈。
  • 非前列腺恶性肿瘤中68Ga-PSMA摄取增高的机制可能为肿瘤新生血管形成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The potential applications of Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT in the imaging of prostate cancer are now well established. A few case reports regarding the potential use of Ga-PSMA PET/CT in nonprostate cancer malignancies are also published. Apparently, the tumor neoangiogenesis is the mechanism attributed to increased Ga-PSMA uptake in the tumor sites in nonprostatic malignancies. We describe the use of Ga-PSMA PET/CT in imaging multiple myeloma. The intense Ga-PSMA avidity of the lesions also opens up the possibility of theranostics with Lu-PSMA.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sasikumar A, Joy A, Pillai MR, et al. 68Ga-PSMA PET/CT Imaging in Multiple Myeloma. Clin Nucl Med. 2017. PMID: 27941377. doi:10.1097/RLU.0000000000001479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。